The latest price target for Daxor (NASDAQ:DXR) was reported by Ascendiant Capital on September 9, 2024. The analyst firm set a price target for $24.75 expecting DXR to rise to within 12 months (a possible 229.56% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Daxor (NASDAQ:DXR) was provided by Ascendiant Capital, and Daxor maintained their buy rating.

There is no last upgrade for Daxor

There is no last downgrade for Daxor.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Daxor, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Daxor was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

While ratings are subjective and will change, the latest Daxor (DXR) rating was a maintained with a price target of $24.50 to $24.75. The current price Daxor (DXR) is trading at is $7.51, which is out of the analyst’s predicted range.